Senior insider sale
Chief Executive Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$25.27M
400K shares
What this filing means
DUBE ERIC M plans to sell 400K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $25.27M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/17/2026ACC: 0001950047-26-009642
DirectorOfficer· Chief Executive Officer
Since Jan 2019
400K
Shares to sell
$25.27M
Approx. market value
108.49K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/17/2026
108.49KTotal acquired108.49K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/17/2026 | Exercise of Stock Options Cash | 108.49K | — |
| Total | 108.49K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
195.84K
Market value
$12.43M
9/16/2026
—Completed
Units to sell
95.67K
Market value
$5.96M
9/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
108.49K
Market value
$6.89M
9/17/2026
Total
Units
400K
Value
$25.27M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 195.84K | $12.43M | — | Completed |
9/15/2026 | 95.67K | $5.96M | — | Completed |
| Planned — Approximate Date | ||||
9/17/2026 | 108.49K | $6.89M | NASDAQ | Planned |
| Total | 400K | $25.27M | ||